BG104240A - Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol - Google Patents

Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol

Info

Publication number: BG104240A
Authority: BG; Bulgaria
Prior art keywords: salmeterol; compositions; methods; optically pure; treating pulmonary
Prior art date: 1997-09-16

Application number

BG104240A

Other languages

Bulgarian (bg)

English (en)

Inventor

Thomas P. Jerussi

Original Assignee

Sepracor Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-16

Filing date

2000-03-14

Publication date

2001-04-30

2000-03-14 Application filed by Sepracor Inc. filed Critical Sepracor Inc.

2001-04-30 Publication of BG104240A publication Critical patent/BG104240A/xx

Links

239000000203 mixture Substances 0.000 title abstract 2
GIIZNNXWQWCKIB-RUZDIDTESA-N (S)-salmeterol Chemical compound C1=C(O)C(CO)=CC([C@H](O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-RUZDIDTESA-N 0.000 title 1
208000019693 Lung disease Diseases 0.000 title 1
GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 abstract 1
230000002411 adverse Effects 0.000 abstract 1
102000016966 beta-2 Adrenergic Receptors Human genes 0.000 abstract 1
108010014499 beta-2 Adrenergic Receptors Proteins 0.000 abstract 1
229940124630 bronchodilator Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
229960004017 salmeterol Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Otolaryngology (AREA)
Chemical Kinetics & Catalysis (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BG104240A 1997-09-16 2000-03-14 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol BG104240A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/931,636 US6254882B1 (en)	1997-09-16	1997-09-16	Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
PCT/US1998/018845 WO1999013867A1 (en)	1997-09-16	1998-09-10	Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol

Publications (1)

Publication Number	Publication Date
BG104240A true BG104240A (en)	2001-04-30

Family

ID=25461118

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG104240A BG104240A (en)	1997-09-16	2000-03-14	Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol

Country Status (19)

Country	Link
US (1)	US6254882B1 (de)
EP (1)	EP1007008B1 (de)
JP (1)	JP2001516715A (de)
KR (1)	KR20010030610A (de)
CN (1)	CN1270515A (de)
AT (1)	ATE268166T1 (de)
AU (1)	AU754275B2 (de)
BG (1)	BG104240A (de)
BR (1)	BR9812643A (de)
CA (1)	CA2304265A1 (de)
CZ (1)	CZ290394B6 (de)
DE (1)	DE69824296T2 (de)
ES (1)	ES2221991T3 (de)
HU (1)	HUP0003488A3 (de)
IL (1)	IL135022A0 (de)
NO (1)	NO20001343D0 (de)
NZ (1)	NZ503563A (de)
SK (1)	SK3722000A3 (de)
WO (1)	WO1999013867A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19921693A1 (de) *	1999-05-12	2000-11-16	Boehringer Ingelheim Pharma	Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
CA2715683A1 (en) *	1999-08-21	2001-03-01	Nycomed Gmbh	Synergistic combination
GB9924992D0 (en) *	1999-10-21	1999-12-22	Glaxo Group Ltd	Pharmaceutical aerosol formulations
EP1523976A3 (de) *	1999-11-23	2005-06-22	Glaxo Group Limited	Pharmazeutische Formulierungen enthaltend Salmeterol
US8337816B2 (en)	2001-09-17	2012-12-25	Glaxo Group Limited	Dry powder medicament formulations
US7378438B2 (en) *	2002-04-19	2008-05-27	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
AU2003278565A1 (en) *	2002-10-25	2004-05-13	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
EP1624866A2 (de) *	2003-05-16	2006-02-15	Arriva Pharmaceuticals, Inc.	Behandlung von atemwegserkrankungen durch inhalation von syntetischen matrix metalloprotease inhibitoren
JPWO2004112791A1 (ja) *	2003-06-23	2006-07-27	協和醗酵工業株式会社	肺疾患の治療および／または予防剤
SI1719507T1 (sl)	2005-04-13	2010-11-30	Astion Dev As	Beta adrenoceptor agonisti za zdravljenje bolezni veznega tkiva kože
US9119777B2 (en)	2008-05-30	2015-09-01	Microdose Therapeutx, Inc.	Methods and compositions for administration of oxybutynin
US8415390B2 (en)	2008-05-30	2013-04-09	Microdose Therapeutx, Inc.	Methods and compositions for administration of oxybutynin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZW6584A1 (en)	1983-04-18	1985-04-17	Glaxo Group Ltd	Phenethanolamine derivatives
IL95936A (en)	1989-10-10	1996-01-19	Glaxo Group Ltd	) R (-) - (- Hydroxy- (A-]]] 6-) 4- Phenylbutoxy (xyl [amino] methyl [-1,3-benzenedimethanol, its preparation and pharmaceutical preparations containing it
GB9024366D0 (en)	1990-11-09	1991-01-02	Glaxo Group Ltd	Medicaments
GB9026005D0 (en)	1990-11-29	1991-01-16	Glaxo Group Ltd	Drug material suitable for micronisation
GB9107196D0 (en) *	1991-04-05	1991-05-22	Sandoz Ag	Improvements in or relating to organic compounds
AU737608B2 (en) *	1997-04-30	2001-08-23	Courage Corporation Pty Ltd	Composition and methods using an eutomer

1997
- 1997-09-16 US US08/931,636 patent/US6254882B1/en not_active Expired - Fee Related
1998
- 1998-09-10 AU AU92283/98A patent/AU754275B2/en not_active Ceased
- 1998-09-10 IL IL13502298A patent/IL135022A0/xx unknown
- 1998-09-10 BR BR9812643-1A patent/BR9812643A/pt not_active IP Right Cessation
- 1998-09-10 HU HU0003488A patent/HUP0003488A3/hu unknown
- 1998-09-10 WO PCT/US1998/018845 patent/WO1999013867A1/en not_active Ceased
- 1998-09-10 SK SK372-2000A patent/SK3722000A3/sk unknown
- 1998-09-10 DE DE69824296T patent/DE69824296T2/de not_active Expired - Fee Related
- 1998-09-10 EP EP98944834A patent/EP1007008B1/de not_active Expired - Lifetime
- 1998-09-10 AT AT98944834T patent/ATE268166T1/de not_active IP Right Cessation
- 1998-09-10 ES ES98944834T patent/ES2221991T3/es not_active Expired - Lifetime
- 1998-09-10 NZ NZ503563A patent/NZ503563A/en unknown
- 1998-09-10 CN CN98809163A patent/CN1270515A/zh active Pending
- 1998-09-10 JP JP2000511490A patent/JP2001516715A/ja not_active Withdrawn
- 1998-09-10 CA CA002304265A patent/CA2304265A1/en not_active Abandoned
- 1998-09-10 CZ CZ2000916A patent/CZ290394B6/cs not_active IP Right Cessation
- 1998-09-10 KR KR1020007002801A patent/KR20010030610A/ko not_active Abandoned
2000
- 2000-03-14 BG BG104240A patent/BG104240A/xx unknown
- 2000-03-15 NO NO20001343A patent/NO20001343D0/no unknown

Also Published As

Publication number	Publication date
SK3722000A3 (en)	2000-07-11
NO20001343L (no)	2000-03-15
DE69824296T2 (de)	2005-06-30
BR9812643A (pt)	2000-08-22
IL135022A0 (en)	2001-05-20
CN1270515A (zh)	2000-10-18
CZ290394B6 (cs)	2002-07-17
ATE268166T1 (de)	2004-06-15
WO1999013867A1 (en)	1999-03-25
CZ2000916A3 (cs)	2000-08-16
EP1007008A1 (de)	2000-06-14
AU754275B2 (en)	2002-11-07
HUP0003488A2 (hu)	2001-02-28
EP1007008B1 (de)	2004-06-02
EP1007008A4 (de)	2002-06-12
AU9228398A (en)	1999-04-05
KR20010030610A (ko)	2001-04-16
JP2001516715A (ja)	2001-10-02
DE69824296D1 (de)	2004-07-08
HUP0003488A3 (en)	2003-05-28
US6254882B1 (en)	2001-07-03
CA2304265A1 (en)	1999-03-25
ES2221991T3 (es)	2005-01-16
NO20001343D0 (no)	2000-03-15
NZ503563A (en)	2002-07-26

Similar Documents

Publication	Publication Date	Title
AU681198B2 (en)	1997-08-21	Preparation of 3,4,4-trisubstituted-piperidinyl-N- alkylcarboxylates and intermediates
EP1007008A4 (de)	2002-06-12	Verfahren und zusammenstellungen zur behandlung von lungenkrankheiten mit optisch reinem s-salmeterol
CA2245768A1 (en)	1998-01-29	Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride
MXPA03005155A (es)	2003-09-10	1,2-difenilazetidinonas novedosas, procesos para su preparacion, farmacos que contienen compuestos y su uso para el tratamiento del metabolismo afectado de los lipidos.
AU7174191A (en)	1991-07-24	Optically pure r(-) albuterol for treating asthma
IL122012A (en)	2001-08-26	Process for the separation of mixtures of enantiomers with optically active resolving agents from a diastereomeric complex
GB9425568D0 (en)	1995-02-15	Process for the preparation of an optically pure enantiomer of formoterol
DK0787715T3 (da)	2000-04-25	Fremgangsmåde til racematspaltning af tramadol
IT1238686B (it)	1993-09-01	Procedimento per la preparazione di levo e destro fenfluramina
DE69907190D1 (de)	2003-05-28	Desformoterol und verfahren zu seiner herstellung
EP0968997A3 (de)	2001-07-25	Verfahren zur Herstellung von S-Aryl-L-cystein und Derivate
FR2719998B1 (fr)	1996-09-27	Composition immunisante anti-hélicobacter pylori à base de catalase.
BR9103481A (pt)	1992-05-12	Composto,estereoisomero,composicao farmaceutica e processo para preparar um composto
EP0474250A3 (en)	1993-04-07	Enzymatic process for separating the optical isomers of racemic 1,2-diols
ATE339423T1 (de)	2006-10-15	Verfahren zur herstellung von 4'-o-substituierten 4'-demethyl-1 desoxypodophyllotoxinderivaten und geometrischen isomeren davon ,und antikrebspräparat, das diese enthält
TR27224A (tr)	1994-12-20	Delta-valerolakton'lardan rasemik karisimlarin ayrilmasina mahsus enzimatik usul.
WO2000010544A3 (en)	2000-05-18	A method for preventing the onset of asthma
DE59203827D1 (de)	1995-11-02	Verfahren zur Herstellung von 2,2-Bis-hydroxymethyl-butandiol-(1,4).
EP1236715A3 (de)	2003-04-23	Verfahren zur Herstellung von S-Aryl-Cystein
AU755526C (en)	2003-07-24	1-(4-arylpiperazin-1-YL)-3-(2-oxopyrrolidin/piperidin-1-YL) propanes used as potential therapeutic agents for hypertension, ischemia, cardiovascular and other adrenergic receptors related disorders, a process for preparing such compounds and a method of treating above diseases using the compounds
AU7236494A (en)	1995-02-13	New method for n-cyclopropylation of aromatic amines, as well as compounds and compositions obtained